In situ re-endothelialization via multifunctional nanoscaffolds

Area of Science:

• Biomaterials Science
• Vascular Biology
• Nanotechnology

Background:

• Endothelial cells lining blood vessels prevent blood clots.
• Damage to endothelium exposes thrombogenic subendothelium, causing pathological vascular changes.
• Current treatments for vascular injury have limitations in promoting regeneration.

Purpose of the Study:

• To develop a biodegradable multifunctional targeting nanoparticle (MTN) scaffold system for vascular injury repair.
• To utilize dual ligands for targeting injured endothelium and promoting endothelial progenitor cell capture.
• To evaluate the efficacy of MTNs in reducing neointimal hyperplasia and enhancing endothelium regeneration.

Main Methods:

• Fabrication of biodegradable urethane-doped polyester (UPE) nanoparticles (400 nm) with glycoprotein 1b (GP1b) and anti-CD34 antibodies.
• In vitro and ex vivo assessment of MTN binding specificity to von Willebrand factor-coated surfaces.
• In vivo studies in a vascular injury model to evaluate neointimal hyperplasia and endothelium regeneration.
• Assessment of cytocompatibility and hemocompatibility of the MTNs.

Main Results:

• MTNs demonstrated specific binding to simulated injured arterial walls and competed with platelets.
• In vivo studies showed a 57% reduction in neointimal hyperplasia and a ~60% increase in endothelium regeneration within 21 days.
• The MTNs were found to be cytocompatible and hemocompatible.

Conclusions:

• Multifunctional targeting nanoparticle (MTN) nanoscaffolds show significant promise for in situ treatment of vascular injuries.
• The dual-ligand strategy effectively targets injured sites and promotes vascular repair.
• This approach offers a novel therapeutic strategy for enhancing endothelium regeneration and reducing pathological vascular remodeling.